Enliven Therapeutics, Inc.
ELVN- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001672619
In the last 90 days, Enliven Therapeutics, Inc. insiders filed 0 open-market purchases and 8 sales; 214 institutions reported holding it in 13F filings for Q2 2026, worth $4.06B in total; no superinvestor holds it.
13F holders, Q2 2026
Institutional positions in Enliven Therapeutics, Inc. as of Jun 30, 2026. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 214
- +46 vs. Q1 2026
- Shares held
- 80.2M
- +17.7M (+28.4%) vs. Q1 2026
- Total value
- $4.06B
- +$1.63B (+67.1%) vs. Q1 2026
- New holders
- 63
- 89 more added
- Sold out
- 17
- 48 more reduced
3 institutions that held it in Q1 2026 haven't filed for Q2 2026 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q1 2026: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting ELVN on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 214 | $4.06B |
| Q1 2026 | 171 | $2.43B |
| Q4 2025 | 126 | $960.9M |
| Q3 2025 | 134 | $1.22B |
| Q2 2025 | 125 | $1.19B |
| Q1 2025 | 122 | $983.9M |
| Q4 2024 | 114 | $1.12B |
| Q3 2024 | 102 | $1.22B |
| Q2 2024 | 93 | $1.13B |
| Q1 2024 | 74 | $780.8M |
| Q4 2023 | 62 | $539.8M |
| Q3 2023 | 61 | $533.8M |
| Q2 2023 | 63 | $797.9M |
| Q1 2023 | 45 | $735.0M |
| Q4 2022 | 36 | $74.7M |
| Q3 2022 | 31 | $18.8M |
| Q2 2022 | 26 | $13.1M |
| Q1 2022 | 31 | $26.2M |
| Q4 2021 | 35 | $33.6M |
| Q3 2021 | 38 | $62.5M |
| Q2 2021 | 31 | $86.3M |
| Q1 2021 | 40 | $92.9M |
Institutions, Q2 2026
Shares, value and share of portfolio for each institution holding Enliven Therapeutics, Inc.; share changes are against Q1 2026.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| First Light Asset Management, LLC | 1,360,750 | $69.1M | 4.20% | +1,158,883+574.1% | Added |
| Geode Capital Management, LLC | 1,407,202 | $71.4M | 0.00% | +340,782+32.0% | Added |
| Bellevue Group AG | 1,490,000 | $75.6M | 1.59% | −830,867−35.8% | Reduced |
| Siren, L.L.C. | 1,774,411 | $90.1M | 1.83% | +1,028,185+137.8% | Added |
| Fairmount Funds Management LLC | 1,855,644 | $94.2M | 6.22% | 00.0% | Unchanged |
| Citadel Advisors LLC | 2,068,992 | $105.0M | 0.06% | +325,077+18.6% | Added |
| Vanguard Capital Management LLC | 2,569,002 | $130.4M | 0.00% | +400,840+18.5% | Added |
| Price T Rowe Associates Inc | 2,903,907 | $147.4M | 0.01% | +2,806,160+2,870.8% | Added |
| Commodore Capital LP | 3,275,000 | $166.2M | 9.90% | 00.0% | Unchanged |
| Vestal Point Capital, LP | 4,000,000 | $203.0M | 4.74% | +750,000+23.1% | Added |
| BlackRock, Inc. | 4,359,704 | $221.3M | 0.00% | +674,997+18.3% | Added |
| Polar Capital Holdings Plc | 6,430,636 | $326.4M | 0.92% | +1,364,703+26.9% | Added |
| OrbiMed Advisors LLC | 6,776,632 | $343.9M | 6.51% | −1,182,906−14.9% | Reduced |
| FMR LLC | 10,025,017 | $508.8M | 0.02% | +3,195,771+46.8% | Added |
| Caption Management, LLC | 0 | $0 | 0.00% | −370,000−100.0% | Sold out |
| Capricorn Fund Managers Ltd | 0 | $0 | 0.00% | −369,400−100.0% | Sold out |
| Jane Street Group, LLC | 0 | $0 | 0.00% | −163,519−100.0% | Sold out |
| DV Trading LLC | 0 | $0 | 0.00% | −95,253−100.0% | Sold out |
| SummitTX Capital, L.P. | 0 | $0 | 0.00% | −68,706−100.0% | Sold out |
| Prelude Capital Management, LLC | 0 | $0 | 0.00% | −52,578−100.0% | Sold out |
| Walleye Capital LLC | 0 | $0 | 0.00% | −37,827−100.0% | Sold out |
| ExodusPoint Capital Management, LP | 0 | $0 | 0.00% | −30,101−100.0% | Sold out |
| Virtu Financial LLC | 0 | $0 | 0.00% | −24,434−100.0% | Sold out |
| Scientech Research LLC | 0 | $0 | 0.00% | −15,827−100.0% | Sold out |
| FORA Capital, LLC | 0 | $0 | 0.00% | −14,723−100.0% | Sold out |
| Jump Financial, LLC | 0 | $0 | 0.00% | −11,661−100.0% | Sold out |
| Quantbot Technologies LP | 0 | $0 | 0.00% | −10,711−100.0% | Sold out |
| Raymond James Financial Inc | 0 | $0 | 0.00% | −10,612−100.0% | Sold out |
| Entropy Technologies, LP | 0 | $0 | 0.00% | −6,101−100.0% | Sold out |
| Rockefeller Capital Management L.P. | 0 | $0 | 0.00% | −25−100.0% | Sold out |
| MAI Capital Management | 0 | $0 | 0.00% | −7−100.0% | Sold out |
| Skopos Labs, Inc. | – | – | – | – | Not filed |
| Janus Henderson Group PLC | – | – | – | – | Not filed |
| CWM, LLC | – | – | – | – | Not filed |